|
SP3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.816500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.415900E-03 |
| Normal-vs-Stage2 |
4.491200E-01 |
| Normal-vs-Stage3 |
8.164000E-01 |
| Normal-vs-Stage4 |
9.338800E-01 |
| Stage1-vs-Stage2 |
3.796000E-01 |
| Stage1-vs-Stage3 |
5.858300E-02 |
| Stage1-vs-Stage4 |
3.113000E-01 |
| Stage2-vs-Stage3 |
5.037400E-01 |
| Stage2-vs-Stage4 |
7.244600E-01 |
| Stage3-vs-Stage4 |
8.415400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.634400E-02 |
| Normal-vs-AfricanAmerican |
1.616440E-01 |
| Normal-vs-Asian |
1.498550E-01 |
| Caucasian-vs-AfricanAmerican |
8.831600E-01 |
| Caucasian-vs-Asian |
8.673600E-01 |
| AfricanAmerican-vs-Asian |
8.261800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.634100E-04 |
| Normal-vs-Female |
3.226200E-01 |
| Male-vs-Female |
1.518560E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.174200E-02 |
| Normal-vs-Extreme_Weight |
1.456480E-03 |
| Normal-vs-Obese |
7.040200E-01 |
| Normal-vs-Extreme_Obese |
4.080100E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.692600E-01 |
| Normal_Weight-vs-Obese |
2.123200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.987400E-01 |
| Extreme_Weight-vs-Obese |
2.944500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.680000E-01 |
| Obese-vs-Extreme_Obese |
1.365810E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.831000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.772200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.555300E-03 |
| Normal-vs-Age(81-100Yrs) |
1.053190E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.144600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.749700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.517800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.794200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.051400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.318200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.428140E-02 |
| Normal-VS-Type2 PRCC |
7.560600E-03 |
| Normal-VS-KIRP CIMP |
1.899610E-01 |
| Normal-VS-Unclassified PRCC |
6.917600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.676000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.381790E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.640000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.184000E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.437500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.790200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.792470E-04 |
| Normal-vs-N1 |
8.547800E-02 |
| Normal-vs-N2 |
4.549200E-01 |
| N0-vs-N1 |
2.544600E-03 |
| N0-vs-N2 |
3.658200E-01 |
| N1-vs-N2 |
3.646300E-02 |
|
|
